Announcement • May 12
ICD Co., Ltd. announced that it expects to receive KRW 25 billion in funding from a group of investors
ICD Co., Ltd. has announced a private placement of Series 6 Unregistered non-interest-free unsecured non-segregated warrants of the company to raise gross proceeds of KRW 25,000,000,000 on May 11, 2026. The transaction includes new and returning investor participation from LS Securities Co., Ltd. of KRW 1,000,000,000, Life Mezzanine Private Equity Investment Trust No. 4 advised by c Co., Ltd. for KRW 1,000,000,000, Rhinos Mezzanine General Private Securities Investment Trust No. 26 advised by Samsung Securities Co., Ltd. for KRW 1,500,000,000, GV Saber-G General Private Investment Trust advised by Mirae Asset Securities Co., Ltd. for KRW 90,000,000, The Time-M2 Private Investment Trust advised by Korea Investment & Securities Co., Ltd. for KRW 500,000,000, Synergy-Shinhan Mezzanine New Technology Investment Fund No. 3 of KRW 1,500,000,000 and others. The Bonds are 100% convertible into 4,002,561 common shares of the company at a conversion price value of KRW 6,246 and carry interest rate of 0% and maturity interest rate of 0%. The conversion billing period starts from May 19, 2027 to April 19, 2031. The transaction has been approved by the board of directors of the company. The Bonds have a maturity date of May 19, 2031. The transaction is expected to close on May 19, 2026.The transaction is subject to 1 year hold period.